Compliance in healthcare has two distinct meanings depending on context. For organizations, it refers to following the laws, regulations, and ethical standards that govern how healthcare is delivered, billed, and documented. For patients, it describes the degree to which someone follows a prescribed treatment plan, from taking medications on schedule to showing up for follow-up appointments. Both forms of compliance carry enormous financial and health consequences.
Organizational Compliance: Following the Rules
Healthcare organizations operate under a dense web of federal and state regulations. Compliance, in this context, means building systems and processes that ensure every part of the operation meets legal requirements. The most prominent of these is the Health Insurance Portability and Accountability Act of 1996 (HIPAA), which established national standards for electronic health transactions, patient data privacy, and unique patient identifiers. The Affordable Care Act later expanded on HIPAA’s provisions, requiring standardized operating rules for transactions, uniform enrollment forms for providers, and more transparent claims processes.
Beyond privacy and billing rules, healthcare compliance also covers fraud and abuse prevention. Federal laws prohibit physicians from referring patients to facilities in which they have a financial interest, and they ban kickbacks or payments in exchange for patient referrals. Violating these rules can result in exclusion from Medicare and Medicaid programs, civil penalties, and criminal prosecution.
Compliance programs within hospitals and clinics typically include a designated compliance officer, regular staff training, internal auditing, and a confidential reporting system for potential violations. The Centers for Medicare and Medicaid Services (CMS) issues regular transmittals that update the rules organizations must follow, covering everything from how claims are submitted electronically to how durable medical equipment is billed. These updates arrive continuously, which means compliance is not a one-time achievement but an ongoing operational requirement.
Patient Compliance vs. Adherence
When healthcare professionals talk about patient compliance, they mean whether a patient follows the treatment plan their provider prescribed. This includes taking medications at the right dose and time, attending scheduled appointments, making recommended lifestyle changes, and completing a full course of treatment. The term carries a specific connotation: compliance is a passive behavior in which a patient is simply doing as they are told, following a list of instructions from their doctor.
This is why many clinicians now prefer the term “adherence.” Where compliance implies the patient’s role is to obey, adherence frames the patient as an active participant who chooses to follow through with treatment while taking responsibility for their own well-being. Adherence suggests a lifestyle change, a daily commitment the patient owns rather than one imposed on them. The distinction matters because how providers frame the relationship affects how they design interventions to help patients stay on track.
How Common Is Non-Compliance?
Failing to follow a treatment plan is remarkably common, especially among people managing chronic conditions. CDC data from a large national survey found that roughly 16% of people with diabetes reported at least one form of cost-related non-adherence, as did about 15% of people with cardiovascular disease and nearly 13% of those with hypertension. These numbers only capture people who couldn’t follow their plan because of cost. The true rates of non-compliance from all causes are considerably higher.
Among those who did struggle with cost, the patterns were telling. The most common behavior, reported by nearly 9 in 10 respondents across all three conditions, was needing medication but not being able to afford it. About 70% reported delaying doses to stretch their supply. More than half said they took less medication than prescribed or skipped doses entirely. Over a third reported doing all three: delaying, reducing, and skipping their medications simultaneously.
Why Patients Don’t Follow Treatment Plans
Cost is one of the most visible barriers, but it’s far from the only one. The reasons people fall out of compliance are layered and often interconnected. Psychological factors like depression, anxiety, health beliefs, and a person’s sense of control over their own health play a role that can equal or exceed socioeconomic factors. Someone who doesn’t believe a medication will help them, or who feels powerless over their condition, is less likely to stick with a regimen regardless of whether they can afford it.
Practical obstacles also pile up. Complex medication schedules with multiple drugs taken at different times of day are harder to follow than simple ones. Side effects that make a patient feel worse in the short term erode motivation. Poor communication with a provider, where a patient doesn’t fully understand why they’re taking something or what to expect, creates gaps in commitment. Transportation challenges, lack of pharmacy access, and unstable housing all compound the problem. A history of substance use has also been identified as a predictor of non-adherence, likely because it intersects with many of these other barriers.
The Cost of Non-Compliance
The financial toll of patients not following treatment plans is staggering. In the United States, avoidable medical spending due to adverse drug events is estimated at $100 to $300 billion per year, with roughly one-third of that attributed directly to medication non-adherence. In Europe, the Organization for Economic Co-operation and Development has linked non-adherence to 200,000 deaths and €125 billion in preventable healthcare costs annually.
These costs vary dramatically by condition. When researchers calculated the average annual cost of non-adherence per person (adjusted to 2024 dollars), diabetes added about $8,300, respiratory diseases about $8,600, and cardiovascular disease roughly $12,100. Mental health conditions pushed the figure to around $14,600 per person per year. The highest costs came from gastrointestinal disease (about $30,800) and osteoporosis (over $43,000), largely because non-adherence in these conditions leads to hospitalizations, fractures, surgeries, and prolonged treatment that could have been avoided.
These aren’t just numbers for policymakers. They reflect real consequences for patients: emergency room visits that wouldn’t have happened, disease progression that could have been slowed, and complications that erode quality of life. For someone managing a chronic illness, understanding that skipping doses or delaying refills carries measurable risk can reframe compliance as self-protection rather than an obligation imposed by a provider.
How Healthcare Organizations Improve Patient Compliance
Efforts to improve compliance have shifted away from blaming patients and toward designing systems that make it easier to follow through. Medication synchronization programs align all of a patient’s prescriptions to a single monthly refill date, reducing the number of pharmacy trips. Reminder systems, whether through apps, text messages, or automated calls, address the simple reality that people forget. Simplified dosing, where a once-daily pill replaces a three-times-daily regimen, consistently improves adherence rates.
On the provider side, motivational interviewing techniques help clinicians explore a patient’s own reasons for wanting to get better, rather than lecturing them about what they should do. Shared decision-making, where the patient helps choose between treatment options based on their own priorities and lifestyle, increases buy-in. Financial assistance programs and generic medication options address cost barriers directly. Some health systems have embedded pharmacists or care coordinators into primary care teams specifically to check in with patients between visits, catch early signs of non-adherence, and troubleshoot barriers before they lead to a crisis.